Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Clinical trial NCT02658019 · COMPLETED
Trial details
- NCT number
- NCT02658019
- Sponsor
- Lynn Feun, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-06
- Primary completion
- 2019-11-10
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.